(Q44932163)

English

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Jacob D Bitran

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Leonard Klein

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Doreen Link

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Jane Kosirog-Glowacki

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Cynthia Stewart

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

David Raack

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Pat Sheahan

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Josephine Lisowski

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Josie Rowen

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Biology of Blood and Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

383-388

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell transplantation for relapsed or refractory aggressive lymphoma in patients over 60 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral blood stem cell transplantation as front-line therapy in patients aged 61 to 65 years: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of feasibility of myeloablative therapy and autologous peripheral stem cell (PBSC) transplantation in the elderly: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Transplant-related mortality in patients older than 60 years undergoing autologous hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Very low toxicity and good quality of life in 48 elderly patients autotransplanted for hematological malignancies: a single center experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a salvage treatment program for relapsing lymphoma: MINE consolidated with ESHAP

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1083-8791%2803%2900099-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1083-8791(03)00099-5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44932163&oldid=2057991393"